HOME >> BIOLOGY >> NEWS
Cancer pain control possible with gene therapy

PITTSBURGH, Oct. 15 By "programming" a herpes simplex virus to deliver a gene-mediated pain-blocking protein at the cellular level, University of Pittsburgh researchers have been able to significantly reduce cancer-related pain in mice with tumors, the researchers report in the November issue of the journal Annals of Neurology. The paper, "Herpes vector-mediated expression of proenkephalin reduces bone cancer pain," is now available online at the journal's Web site, http://www.interscience.wiley.com/jpages/0364-5134/.

"Chronic pain is notoriously difficult to treat effectively," said co-author Joseph Glorioso, Ph.D., chairman of the department of molecular genetics and biochemistry and director of the Molecular Medicine Institute at the University of Pittsburgh School of Medicine, and president of the American Society of Gene Therapy. "We've been able to show that using this virus can significantly reduce bone cancer pain at least in mice."

The investigators are pursuing necessary approvals to begin a clinical trial in patients with severe pain resulting from metastatic cancer, and hope to start enrolling patients sometime next year.

"We are excited about the possibility that this approach may help to control pain in patients who can't get complete relief from the maximum current treatment," said senior author David Fink, M.D., professor of neurology and molecular genetics and biochemistry at the University of Pittsburgh School of Medicine and chief of neurology and director of the Geriatric Research Education and Clinical Center at the Veterans Administration Pittsburgh Healthcare System.

Drs. Fink, Glorioso and their colleagues created an inactivated herpes simplex virus that carries the human gene for proenkaphalin, a naturally occurring painkilling peptide, a combination of amino acids.

Mice with tumors in a leg bone that received injections with the alte
'"/>

Contact: Michele Baum
412-647-3555
University of Pittsburgh Medical Center
15-Oct-2002


Page: 1 2

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Cancer gene MYC emerging as key research target
5. Cancer patient, heal thyself
6. USC researcher named General Motors Cancer Research Scholar
7. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
8. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
9. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
10. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
11. National Cancer Gene Therapy Foundation gives $4.0 million in research grants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2018)... PRUSSIA, Pa. (PRWEB) , ... November 29, 2018 ... ... equity investment in Semba Biosciences with the intention of acquiring full ownership. The ... Equity Participation Agreement was executed on November 14, 2018. “We are extremely pleased ...
(Date:11/27/2018)... ... November 27, 2018 , ... LabArchives today ... together to integrate the LabArchives Classroom Edition with Current Protocols Essential Laboratory Techniques ... available beginning January of 2019. , The integration of LabArchives Classroom ...
(Date:11/20/2018)... , ... November 19, 2018 , ... ... in the Bay Area -- the first and only non-invasive buttock lift procedure, ... is FDA cleared to strengthen, tone and firm the buttocks to provide a ...
Breaking Biology News(10 mins):
(Date:11/29/2018)... ... ... RAGS, today announced the closing of a $1.5 million Second Seed round investment. ... board member Jeremy Andrus, CEO of Traeger Grills, as well as James Ho of ... to accelerate its growth and expand the product line. RAGS has now raised a ...
(Date:11/27/2018)... ... , ... New patients in need of a dental crown in ... without a referral. Dr. Myers has many years of experience improving patient smiles with ... custom crowns. , As a dedicated cosmetic dentist , Dr. Myers has ...
(Date:11/20/2018)... (PRWEB) , ... November 19, 2018 , ... ... pleased to announce the release of the Chinese translation of Best Practices: Recommendations ... 2018, is a practice-changing publication aimed at advancing the science of biobanking to ...
(Date:11/20/2018)... ... ... Each year Forbes receives thousands of nominations for candidates wishing to be ... under 30 years of age. The Forbes 30 Under 30 list showcases the top ... Capital and Science. , In 2017, Visikol CEO Dr. Michael Johnson was named ...
Breaking Biology Technology:
Cached News: